Interesting to see RespireRX pop up in this article. IHL used to...

Interesting to see RespireRX pop up in this article. IHL used to have an exclusive agreement with them a few years back. I believe it has since expired.

While they are slightly more advanced in terms of trial progression (moving to phase 3), our initial results were more impressive. I expect due to the synergistic properties of our drug combination.

Can anyone remind me the other reasons RespireRX trials are not a threat to our TAM? I remember having this conversation here a while back but can't quite remember now. @MickeyMantle536 I feel like you're across this.